Silverarc Capital Management »

Monte Rosa Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.1M 695k 7.41
2023-06-30 $213k 31k 6.85
2023-03-31 $243k 31k 7.79